Results 151 to 160 of about 116,493 (265)

Developing an Intervention Framework to Prevent Surgical Complications in Patients With Metabolic Syndrome: A Qualitative Study of Health Professional Perspectives on Barriers and Enablers

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Metabolic syndrome (MetS) is a cluster of risk factors, including cardiovascular disease, diabetes, chronic hypertension, obesity, and hypercholesterolemia, which collectively increase the risk of chronic diseases and adverse health outcomes.
Philip Norris   +7 more
wiley   +1 more source

Potentially‐Preventable Deaths Following Colorectal Surgery: A National Retrospective Cohort Study of Surgical Mortality

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Many deaths after colorectal resection may be preventable, but administrative datasets provide limited insights into the clinical processes leading to mortality. We used the Australian and New Zealand Audit of Surgical Mortality (ANZASM) to quantify potentially preventable deaths after colorectal surgery and describe modifiable ...
Cameron I. Wells   +6 more
wiley   +1 more source

Oncovascular Resection in Pelvic Exenteration: A Systematic Review

open access: yesANZ Journal of Surgery, EarlyView.
Risk of bias assessment using ROBINS‐1 V2. Selection of the reported result (D7) was judged based on omission of key expected outcomes, including margin status (R0 resection), postoperative complications and mortality. Studies not reporting these outcomes were classified as serious risk of bias, while those with broadly complete but non‐pre‐specified ...
Joshua Richard Burke   +6 more
wiley   +1 more source

Preparedness for maternal and offspring health surveillance in pandemics: Lessons learned from studies on COVID‐19 using Scandinavian registry data

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
The Scandinavian registries are unique resources that should be used in pandemics to understand risks to pregnant women and their developing fetuses. Abstract When the COVID‐19 pandemic emerged, pregnant women were quickly identified as a high‐risk group.
Maria C. Magnus   +5 more
wiley   +1 more source

Vaccinations During Pregnancy Protect the Mother–Infant Dyad and Are Generally Safe

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Vaccination in pregnancy has a critical impact on mothers, foetuses and infants. The aim of this paper was to summarise key points presented by experts attending the 12th Maria Delivoria‐Papadopoulos Perinatal Symposium in March 2025 and further expand and update them.
Ariadne Malamitsi‐Puchner   +2 more
wiley   +1 more source

Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins   +6 more
wiley   +1 more source

International Delphi consensus on feminising genital surgery in assigned‐male‐at‐birth individuals

open access: yesBJU International, EarlyView.
Objective To achieve an international expert consensus among surgeons on the indications, contraindications, and perioperative management of feminising genital surgery (FGS) for assigned‐male‐at‐birth (AMAB) individuals, using a Delphi process. Methods A two‐round on‐line Delphi survey (May–July 2025) followed by a final consensus meeting (September ...
Marta Pezzoli   +30 more
wiley   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Cardiotoxicity of BRAF/MEK inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy